BCR-ABL1 Fusion Protein Expression
3 clinical trials · Condition
◉ Watch BCR-ABL1 Fusion Protein Expression
| Record | Firm | Date |
|---|---|---|
| Study of Efficacy and Safety of Flumatinib Combined With Chemotherapy in Ph Positive ALL (NCT04375683) | Zhongda Hospital | 2020-03-01 |
| Blinatumomab, Methotrexate, Cytarabine, and Ponatinib in Treating Patients With Philadelphia Chromosome-Positive, or BCR-ABL Positive, or Relapsed/Refractory, Acute Lymphoblastic Leukemia (NCT03263572) | M.D. Anderson Cancer Center | 2017-11-29 |
| Combination Chemotherapy and Dasatinib in Treating Participants With Philadelphia Positive or BCR-ABL Positive Acute Lymphoblastic Leukemia. (NCT00390793) | M.D. Anderson Cancer Center | 2006-09-28 |
Track BCR-ABL1 Fusion Protein Expression automatically
Every clearance here is in the API, with alerts when new ones post.